Evidence map›Paper›PMID 41659826›Full record

ArticleKidney medicine2026

Mitochondrial DNA Analysis Should Be Considered in the Genetic Assessment of Focal Segmental Glomerulosclerosis or Unexplained Chronic Kidney Disease: A Case Report.

Chloe Borden, Iman Chaudhry, Rhyan Maditz, Sarah Mazzola, Ronit Salomon Kent, Kristen Tomaszewski, Xiangling Wang

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Diagnostic Yield of Exome Sequencing after Negative or Inconclusive Kidney Genes Panel Testing.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chloe BordenCleveland Clinic Lerner College of Medicine, Cleveland, OH.
Iman ChaudhryDepartment of Kidney Medicine, Medical Specialties Institute, Cleveland Clinic, Cleveland, OH.
Rhyan MaditzDepartment of Kidney Medicine, Medical Specialties Institute, Cleveland Clinic, Cleveland, OH.
Sarah MazzolaDepartment of Medical Genetics and Genomics, Medical Specialties Institute, Cleveland Clinic, Cleveland, OH.
Ronit Salomon KentGeneDx, LLC, Gaithersburg, MD.
Kristen TomaszewskiDepartment of Anatomic Pathology, Cleveland Clinic, Cleveland, OH.
Xiangling WangCleveland Clinic Lerner College of Medicine, Cleveland, OH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic testing is increasingly used to assist the precise diagnosis and clinical management of suspected genetic kidney diseases; however, mitochondrial DNA (mtDNA) analysis remains underutilized. Here we report a 61-year-old man who presented with chronic kidney disease (CKD), microscopic hematuria since childhood, bilateral sensorineural hearing loss (SNHL), and peripheral polyneuropathy. Laboratory reports showed serum creatinine 1.5 mg/dL with an estimated glomerular filtration rate of 55 mL/min/1.73m

Indexed as

case reportchronic kidney disease (CKD)focal segmental glomerulosclerosis (FSGS)genetic testingMitochondrial disorders

Identifiers

PMID41659826
PMCPMC12874128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.